Skip to main content

Table 1 Sociodemographic and clinical features of patients in four groups (N = 433)

From: Anesthetic effect of different doses of butorphanol in patients undergoing gastroscopy and colonoscopy

 

Group A (N = 103)

Group B (N = 116)

Group C (N = 117)

Group D (N = 97)

F / χ 2

P

Age (year)

50 (41–55)

52 (41–58)

48 (42–55)

51 (43–58)

2.029

0.566

Male (%)

53 (51.5)

66 (56.9)

58 (49.6)

52 (53.6)

1.369

0.713

Weight (kg)

68 (61–75)

69 (64–75)

66 (60–74)

67 (60–73)

5.606

0.132

ASA grade (I/II/III)

73/29/1

75/40/1

74/42/1

75/20/1

7.847

0.250

Combined diabetes or hypertension (%)

9 (8.7)

12 (10.3)

8 (6.8)

7 (8.2)

2.836

0.970

Removal of polyps (%)

10 (9.7)

12 (10.3)

10 (8.5)

12 (12.4)

0.880

0.830

  1. The data are presented as the median and interquartile range (M (P25, P75) or mean ± standard deviation or numbers of patients. Group A: Butorphanol 2.5 μg/kg group; Group B: Butorphanol 5 μg/kg group; Group C: Butorphanol 7.5 μg/kg group; Group D: Butorphanol 10 μg/kg group; P: P value; F/χ2: F value or χ2